BIOTECHNOLOGY VALUE FUND II LP - Insider Non-Derivative Transactions at Kymera Therapeutics, Inc. (KYMR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 3, 2023, BIOTECHNOLOGY VALUE FUND II LP's relationship to Kymera Therapeutics, Inc. (KYMR) is DirectorOther, and currently has 2,656,191 shares of Common Stock, $0.0001 par value.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KYMR insiders.
Data Source: SEC.
BIOTECHNOLOGY VALUE FUND II LP - Insider Non-Derivative Transactions of KYMR Common Stock, $0.0001 par value
BIOTECHNOLOGY VALUE FUND II LP - Insider Non-Derivative Transactions at KYMR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 4, 2023 | P -- (Common Stock, $0.0001 par value) | 10106 | 14.07 | 294632 |
| Nov 4, 2023 | P -- (Common Stock, $0.0001 par value) | 83708 | 14.07 | 2104075 |
| Nov 4, 2023 | P -- (Common Stock, $0.0001 par value) | 103885 | 14.07 | 2656191 |
| Nov 3, 2023 | P -- (Common Stock, $0.0001 par value) | 26772 | 11.64 | 284526 |
| Nov 3, 2023 | P -- (Common Stock, $0.0001 par value) | 132016 | 11.64 | 2020367 |
| Nov 3, 2023 | P -- (Common Stock, $0.0001 par value) | 57618 | 11.64 | 2552306 |